Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Keybanc analyst Eric Heath downgraded the rating for C3.ai, Inc. (NYSE:AI) from Sector Weight to Underweight and announced a $29 price target. C3.ai shares closed at $39.69 on Wednesday. See how other analysts view this stock.
• Wells Fargo analyst Derek Archila downgraded Viridian Therapeutics, Inc. (NASDAQ:VRDN) from Overweight to Equal-Weight and announced a $27 price target. Viridian Therapeutics shares closed at $18.93 on Wednesday. See how other analysts view this stock.
• Jefferies analyst Samad Samana downgraded the rating for NICE Ltd. (NASDAQ:NICE) from Buy to Hold and lowered the price target from $215 to $200. NICE shares closed at $181.75 on Wednesday. See how other analysts view this stock.
• Telsey Advisory Group analyst Dana Telsey downgraded European Wax Center, Inc. (NASDAQ:EWCZ) from Outperform to Market Perform and cut the price target from $8 to $6. European Wax Center shares closed at $5.56 on Wednesday. See how other analysts view this stock.
• Wells Fargo analyst Derek Archila downgraded the rating for Cabaletta Bio, Inc. (NASDAQ:CABA) from Overweight to Equal-Weight and lowered the price target from $12 to $6. Cabaletta Bio shares closed at $2.29 on Wednesday. See how other analysts view this stock.

Considering buying AI stock? Here's what analysts think:

Read This Next:

• Dow Dips Over 1,100 Points, Falling For 10th Session As Powell Adopts Hawkish Stance: Greed Index Moves To 'Fear' Zone